Methods for preventing or reducing the number of gout flares using xanthine oxidoreductase inhibitors and antiinflammatory agents
Details for Australian Patent Application No. 2008206231 (hide)
International Classifications
Event Publications
13 August 2009 PCT application entered the National Phase
PCT publication WO2008/089296 Priority application(s): WO2008/089296
17 September 2009 Alteration of Name
The name of the applicant has been altered to Takeda Pharmaceuticals, North Amercia, Inc.
26 April 2012 Alteration of Name
The name of the applicant has been altered to Takeda Pharmaceuticals U.S.A., Inc. 2009
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2008206239-Advanced pattern recognition systems for spectral analysis
2008206221-Stable reagents and kits useful in loopmediated isothermal amplification (LAMP)
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
![](/images/main/3dbox_small.png)
- Editable Word format reports
- For IP Professionals
- Multiuser